奥翔药业 - Financials

奥翔药业 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012
+Revenue	795.0M	817.0M	765.0M	570.0M	409.0M	308.0M	244.0M	240.0M	199.0M	263.0M	201.0M	121.0M	58.9M
Revenue Growth %	-2.7%	6.8%	34.2%	39.4%	32.8%	26.2%	1.7%	20.6%	-24.3%	30.8%	66.1%	105.3%	--
Total Revenue	795.0M	817.0M	765.0M	570.0M	409.0M	308.0M	244.0M	240.0M	199.0M	263.0M	201.0M	121.0M	58.9M
Cost Of Revenue	364.0M	367.0M	371.0M	258.0M	178.0M	148.0M	135.0M	95.1M	88.8M	127.0M	92.7M	64.8M	43.3M
+Gross Profit	431.0M	450.0M	394.0M	312.0M	231.0M	160.0M	109.0M	144.9M	110.2M	136.0M	108.3M	56.2M	15.6M
Gross Margin %	54.2%	55.1%	51.5%	54.7%	56.5%	51.9%	44.7%	60.4%	55.4%	51.7%	53.9%	46.5%	26.5%
Total Operating Cost	592.0M	542.0M	519.0M	423.0M	317.0M	257.0M	208.0M	182.0M	137.0M	197.0M	175.0M	102.0M	56.1M
Selling Expenses	16.8M	18.1M	20.8M	7.2M	6.8M	9.0M	6.4M	5.3M	4.4M	4.7M	3.3M	2.4M	868,900
Admin Expenses	106.0M	100.0M	93.8M	74.1M	56.9M	48.9M	40.2M	35.3M	47.4M	56.6M	69.2M	29.0M	8.6M
Rd Expenses	100.0M	78.1M	67.1M	68.8M	50.8M	47.7M	34.4M	29.8M	--	--	--	--	--
Finance Expenses	-23.6M	-33.7M	-42.2M	5.8M	15.7M	-6.9M	-12.8M	11.6M	-2.6M	1.2M	5.2M	4.9M	2.7M
+Operating Income	241.0M	291.0M	258.0M	160.0M	96.6M	61.1M	47.2M	60.3M	62.6M	65.3M	26.7M	18.5M	2.8M
Operating Margin %	30.3%	35.6%	33.7%	28.1%	23.6%	19.8%	19.4%	25.1%	31.5%	24.8%	13.3%	15.3%	4.8%
Non Operating Income	1,400	427,200	14,000	180,400	--	118,500	624,200	--	2.7M	5.3M	1.0M	53,200	800.00
Non Operating Expenses	944,900	488,200	1.9M	941,200	1.1M	625,500	545,000	145,900	108,600	292,600	254,700	330,900	54,600
Investment Income	22.9M	5.2M	1.4M	-1.7M	580,000	2.4M	3.3M	323,700	--	--	--	--	14,200
Fair Value Change Income	5.5M	-4.5M	4.9M	13.3M	-5.2M	-315,300	2.4M	-2.2M	734,100	--	--	--	--
Asset Impairment Loss	9.4M	5.3M	1.8M	3.7M	4.3M	8.0M	1.7M	4.1M	-2.2M	6.5M	3.4M	1.1M	665,900
Other Income	9.6M	15.5M	5.5M	2.1M	8.9M	8.1M	5.8M	4.5M	--	--	--	--	--
Income Before Tax	240.0M	291.0M	256.0M	159.0M	95.5M	60.6M	47.3M	60.1M	65.3M	70.3M	27.5M	18.3M	2.8M
Income Tax	33.4M	36.9M	20.5M	13.5M	8.7M	4.2M	3.5M	7.1M	7.9M	9.4M	6.0M	2.7M	479,900
+Net Income	207.0M	254.0M	235.0M	146.0M	86.8M	56.4M	43.9M	53.0M	57.3M	60.9M	21.5M	15.6M	2.3M
Net Margin %	26.0%	31.1%	30.7%	25.6%	21.2%	18.3%	18.0%	22.1%	28.8%	23.1%	10.7%	12.9%	3.9%
Net Income Attributable	207.0M	254.0M	235.0M	146.0M	86.8M	56.4M	43.9M	53.0M	57.3M	60.9M	21.5M	15.6M	2.3M
Eps Basic	0.25	0.31	0.41	0.36	0.32	0.25	0.27	0.37	0.48	0.56	0.45	0.35	0.09
Eps Diluted	0.25	0.31	0.41	0.36	0.32	0.25	0.27	0.37	0.48	0.56	0.45	0.35	0.09

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012
Cash And Equivalents	1.1B	1.1B	609.0M	565.0M	739.0M	342.0M	278.0M	240.0M	109.0M	58.2M	8.8M	7.9M	3.3M
Trading Financial Assets	2.2M	--	4.0M	110.0M	--	542,500	857,800	--	734,100	--	--	--	--
Accounts Receivable	192.0M	133.0M	135.0M	66.2M	45.6M	62.4M	75.7M	80.4M	68.1M	110.0M	49.0M	4.4M	14.1M
Notes Receivable	--	--	--	--	--	--	--	--	--	800,000	200,000	44,500	--
Notes And Accounts Receivable	192.0M	133.0M	135.0M	66.2M	45.6M	62.4M	75.7M	80.4M	68.1M	111.0M	49.2M	4.5M	14.1M
Prepayments	1.2M	3.8M	3.8M	4.9M	1.3M	754,000	2.4M	1.0M	877,900	696,900	1.6M	627,600	607,200
Inventory	401.0M	365.0M	321.0M	243.0M	190.0M	188.0M	129.0M	126.0M	60.1M	45.2M	47.8M	31.6M	7.7M
Total Current Assets	1.7B	1.7B	1.1B	1.0B	980.0M	602.0M	536.0M	509.0M	239.0M	215.0M	110.0M	49.2M	27.5M
Fixed Assets	--	517.0M	266.0M	222.0M	223.0M	170.0M	186.0M	164.0M	128.0M	112.0M	78.4M	80.9M	55.2M
Fixed Assets Total	543.0M	517.0M	266.0M	222.0M	223.0M	170.0M	186.0M	164.0M	128.0M	112.0M	78.4M	80.9M	55.2M
Construction In Progress	--	510.0M	661.0M	358.0M	66.9M	56.6M	38.7M	25.9M	37.9M	32.3M	32.8M	9.4M	7.1M
Construction In Progress Total	496.0M	526.0M	685.0M	379.0M	77.0M	75.5M	41.6M	28.6M	39.0M	33.8M	33.0M	11.0M	9.1M
Intangible Assets	155.0M	150.0M	154.0M	156.0M	59.3M	35.2M	35.7M	36.8M	37.8M	38.9M	38.3M	37.5M	30.6M
Total Non Current Assets	1.3B	1.3B	1.2B	819.0M	402.0M	285.0M	266.0M	232.0M	207.0M	186.0M	151.0M	130.0M	95.1M
Total Assets	3.0B	3.0B	2.3B	1.8B	1.4B	886.0M	802.0M	742.0M	446.0M	402.0M	260.0M	179.0M	123.0M
Short Term Borrowings	270.0M	300.0M	160.0M	65.1M	41.0M	45.0M	72.0M	--	27.4M	49.9M	48.5M	26.5M	13.5M
Accounts Payable	208.0M	301.0M	370.0M	200.0M	111.0M	93.6M	73.4M	90.9M	86.5M	106.0M	84.8M	56.3M	47.2M
Advance Receipts	--	--	--	--	--	1.7M	2.6M	1.2M	396,800	795,700	35,000	204,100	370,100
Contract Liabilities	908,500	7.1M	12.6M	23.2M	2.5M	--	--	--	--	--	--	--	--
Total Current Liabilities	675.0M	771.0M	745.0M	530.0M	244.0M	232.0M	197.0M	171.0M	185.0M	206.0M	180.0M	119.0M	76.2M
Long Term Borrowings	--	--	72.7M	44.9M	--	--	--	--	13.2M	5.0M	--	27.2M	36.0M
Total Non Current Liabilities	36.0M	39.0M	109.0M	54.3M	10.9M	8.8M	7.9M	6.1M	17.4M	7.7M	1.8M	27.2M	36.0M
Total Liabilities	710.0M	810.0M	854.0M	585.0M	255.0M	241.0M	204.0M	177.0M	203.0M	214.0M	182.0M	146.0M	112.0M
Paid In Capital	830.0M	593.0M	402.0M	287.0M	239.0M	160.0M	160.0M	160.0M	120.0M	90.0M	46.5M	15.0M	8.0M
Capital Reserve	440.0M	677.0M	395.0M	510.0M	557.0M	229.0M	229.0M	229.0M	27,600	21.6M	16.1M	--	--
Surplus Reserve	130.0M	105.0M	76.6M	51.1M	37.2M	28.7M	23.1M	18.7M	13.4M	7.6M	1.6M	1.8M	235,600
Retained Earnings	872.0M	767.0M	589.0M	408.0M	294.0M	228.0M	186.0M	158.0M	110.0M	68.8M	14.0M	16.1M	2.1M
Equity Attributable	2.3B	2.1B	1.5B	1.3B	1.1B	645.0M	598.0M	565.0M	243.0M	188.0M	78.2M	32.9M	10.4M
Total Equity	2.3B	2.1B	1.5B	1.3B	1.1B	645.0M	598.0M	565.0M	243.0M	188.0M	78.2M	32.9M	10.4M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012
Cash From Sales	758.0M	853.0M	729.0M	601.0M	448.0M	332.0M	258.0M	235.0M	259.0M	231.0M	174.0M	147.0M	56.7M
Tax Refunds Received	41.6M	38.6M	29.9M	5.6M	9.9M	17.5M	6.9M	14.5M	3.8M	1.8M	1.1M	907,600	477,000
Total Operating Cash Inflow	854.0M	1.0B	890.0M	655.0M	522.0M	390.0M	364.0M	291.0M	298.0M	258.0M	185.0M	185.0M	92.2M
Cash Paid For Goods	332.0M	456.0M	456.0M	214.0M	205.0M	142.0M	172.0M	124.0M	103.0M	93.7M	96.4M	93.2M	34.0M
Cash Paid To Employees	189.0M	187.0M	154.0M	104.0M	83.3M	62.5M	55.4M	45.2M	34.2M	27.1M	18.2M	13.6M	3.7M
Taxes Paid	54.7M	37.2M	36.2M	21.7M	12.7M	13.2M	11.7M	11.2M	18.5M	26.0M	12.8M	5.8M	1.2M
Total Operating Cash Outflow	676.0M	808.0M	769.0M	481.0M	384.0M	302.0M	352.0M	242.0M	205.0M	204.0M	163.0M	170.0M	93.3M
Operating Cash Flow	178.0M	222.0M	121.0M	174.0M	138.0M	87.7M	11.5M	49.3M	93.2M	53.6M	21.5M	15.7M	-1.1M
Total Investing Cash Inflow	37.6M	6.9M	620.0M	517.0M	116.0M	199.0M	244.0M	13.6M	1.8M	1.1M	2.1M	73,000	20.0M
Total Investing Cash Outflow	158.0M	182.0M	798.0M	949.0M	221.0M	201.0M	281.0M	128.0M	42.8M	42.8M	23.1M	36.7M	51.5M
Investing Cash Flow	-120.0M	-175.0M	-178.0M	-432.0M	-105.0M	-2.2M	-36.7M	-114.0M	-40.9M	-41.7M	-21.0M	-36.6M	-31.5M
Cash From Borrowings	270.0M	330.0M	235.0M	220.0M	81.0M	117.0M	159.0M	82.9M	72.8M	76.8M	62.6M	71.1M	57.5M
Dividends And Interest Paid	84.2M	57.4M	37.7M	20.0M	13.4M	11.4M	14.2M	3.0M	5.5M	4.2M	5.0M	4.4M	2.5M
Debt Repayments	300.0M	272.0M	103.0M	151.0M	84.9M	144.0M	87.0M	144.0M	67.1M	97.5M	57.5M	50.1M	27.0M
Total Financing Cash Inflow	291.0M	841.0M	247.0M	220.0M	506.0M	117.0M	159.0M	368.0M	72.8M	126.0M	62.6M	78.1M	57.5M
Total Financing Cash Outflow	399.0M	371.0M	152.0M	183.0M	116.0M	155.0M	101.0M	165.0M	72.6M	102.0M	62.5M	54.5M	29.5M
Financing Cash Flow	-108.0M	470.0M	94.9M	37.0M	390.0M	-38.5M	57.8M	202.0M	212,200	24.0M	98,100	23.6M	28.0M
Net Change In Cash	-39.4M	524.0M	74.8M	-232.0M	403.0M	50.7M	46.1M	127.0M	52.5M	36.0M	596,600	2.7M	-4.6M
Ending Cash Balance	1.0B	1.1B	564.0M	489.0M	721.0M	318.0M	267.0M	221.0M	93.5M	41.1M	5.1M	4.5M	1.8M
Capex	111.0M	163.0M	272.0M	311.0M	93.0M	49.6M	55.1M	54.4M	42.8M	42.8M	23.1M	36.7M	37.5M